Bioaffinity technologies, inc.BIAF.US Overview

US StockHealthcare

(No presentation for BIAF)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

BIAF Overall Performance

BIAF AI Analysis & Strategy

BIAF Recent Performance

3.31%

Bioaffinity technologies, inc.

0.81%

Avg of Sector

-1.14%

S&P500

BIAF PowerScanner

BIAF Key Information

BIAF Valuation Metrics

BIAF Earnings Table

BIAF Profile

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.